Galactomannan antigenemia in patient with invasive aspergillosis according to number of serum samples
. | 1 positive sample, % . | 2 or more positive samples, % . | ||||||
---|---|---|---|---|---|---|---|---|
Sens . | Spec . | PPV . | NPV . | Sens . | Spec . | PPV . | NPV . | |
Proven IA | 100 | 94.6 | 68.1 | 100 | 100 | 98.1 | 85.7 | 100 |
Probable IA | 66.6 | 94.6 | 30 | 98.8 | 55.5 | 98.1 | 50 | 98.4 |
Proven + probable IA | 92.3 | 94.6 | 72 | 98.8 | 89.7 | 98.1 | 87.5 | 98.4 |
Possible IFI | 11.1 | 94.6 | 30 | 83.8 | 7.4 | 98.1 | 44.4 | 83.8 |
. | 1 positive sample, % . | 2 or more positive samples, % . | ||||||
---|---|---|---|---|---|---|---|---|
Sens . | Spec . | PPV . | NPV . | Sens . | Spec . | PPV . | NPV . | |
Proven IA | 100 | 94.6 | 68.1 | 100 | 100 | 98.1 | 85.7 | 100 |
Probable IA | 66.6 | 94.6 | 30 | 98.8 | 55.5 | 98.1 | 50 | 98.4 |
Proven + probable IA | 92.3 | 94.6 | 72 | 98.8 | 89.7 | 98.1 | 87.5 | 98.4 |
Possible IFI | 11.1 | 94.6 | 30 | 83.8 | 7.4 | 98.1 | 44.4 | 83.8 |
Proven IFI and probable IFI were excluded from the analysis.
Sens indicates sensitivity; spec, specificity; for other abbreviations, see Tables 1 and 2.